Table 5.

Relationships between Overall Survival Time and Progression-Free Survival and Expression of TIMP-2 in the Subgroup of FIGO Stage III Patients Treated with Platinum-Based Drugs and Paclitaxel (n=35)

	TIPM-2c	TIMP-2s	TIMP2c-s
Overall survival, p value	0.4231	0.0743	0.0010
Progression-free survival, p value	0.9465	0.0321	0.0034

FIGO, International Federation of Gynecology and Obstetrics; TIMP-2, tissue inhibitor of metalloproteinase 2; TIPM-2c, TIMP-2 expression in tumor compartment (cancer cells); TIMP-2s, TIMP-2 expression in the stromal compartment; TIMP2c-s, TIMP-2 coexpression in tumor and stromal compartments.